Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016

Key points

The purpose of this publication was to report ALS prevalence estimates in 2016.

Screenshot of the first two pages of the paper

Affiliates

Paul Mehta [1] , Jaime Raymond [1] , Reshma Punjani [1] , Theodore Larson [1] , Frank Bove [1], Wendy Kaye [2] , Lorene M. Nelson [3] , Barbara Topol [3] , Moon Han [1] , Oleg Muravov [1] , Corina Genson [1] , Bryn Davis [1] , Thomas Hicks [4] , and Kevin Horton [1]

  1. Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention
  2. McKing Consulting Corporation
  3. Department of Epidemiology and Population Health, Stanford University School of Medicine
  4. Carter Consulting, Inc

Journal

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Summary

The National ALS Registry reports the most recent ALS prevalence estimates. In 2016, the Registry conservatively identified 16,424 adult persons who met the Registry definition of ALS for an age-adjusted prevalence rate of 5.2 per 100,000 U.S. population. The pattern of patient characteristics (e.g., age, sex, and race/ethnicity) has not changed from previous Registry reports.

Link to Paper

Find the paper here!

Print
Content Source:
Agency for Toxic Substances and Disease Registry